The Sarver Heart Center Cardiogenic Shock Program focuses on advancing the understanding of cardiogenic shock and cardiac arrest through integrated clinical investigation, translational science, and multidisciplinary collaboration. The program brings together expertise in advanced heart failure, interventional cardiology, cardiac surgery, critical care, and cardiovascular research to study complex hemodynamic failure and improve outcomes in critically ill patients.
The program integrates cardiovascular research, advanced hemodynamic assessment, and multidisciplinary expertise in cardiogenic shock.
The Sarver Heart Center has a longstanding history of innovation in advanced cardiovascular disease, including early milestones in heart transplantation, mechanical circulatory support, and resuscitation science. Building on this foundation, current efforts focus on understanding the systems biology of cardiogenic shock, optimizing mechanical circulatory support strategies, and refining medical therapies for patients with severe cardiac dysfunction.
The program reflects a highly integrated academic environment, where investigators study the physiologic, molecular, and clinical determinants of cardiogenic shock and cardiac arrest. These efforts aim to better define disease mechanisms, improve risk stratification, and identify opportunities for earlier recognition and intervention in critically ill populations.
Work in this area is closely aligned with ongoing initiatives in myocardial recovery, mechanical circulatory support, and precision cardiovascular medicine, contributing to a broader effort to improve outcomes in advanced heart failure and critical cardiovascular illness.
Program Themes
Systems Biology of Cardiogenic Shock
Investigating the complex physiologic and molecular mechanisms underlying cardiogenic shock and cardiac arrest, including multiorgan dysfunction and hemodynamic failure.
Mechanical Circulatory Support
Advancing understanding of short- and long-term mechanical circulatory support strategies, including ECMO and percutaneous support devices, and their role in stabilizing critically ill patients.
Clinical Research and Outcomes
Supporting institutional registries, multicenter studies, and outcomes research focused on cardiogenic shock, cardiac arrest, and the optimization of therapeutic strategies.
Precision Medicine and Risk Stratification
Exploring biomarkers, transcriptomics, and machine learning approaches to improve early identification, risk stratification, and personalized management of cardiogenic shock.
Multidisciplinary Collaboration
Bringing together expertise across cardiology, cardiac surgery, critical care, and translational science to address the complexity of cardiogenic shock and develop coordinated approaches to care and research.
Education and Training
Providing advanced training opportunities for fellows and trainees in cardiology, critical care, and cardiothoracic surgery, including exposure to mechanical circulatory support and complex hemodynamic management.
Program Leadership
The Cardiogenic Shock Program is led by Deepak Acharya, MD, MSPH, MBA, Professor of Medicine, whose work focuses on cardiogenic shock, mechanical circulatory support, and advanced heart failure. Dr. Acharya is board certified in Interventional Cardiology and Advanced Heart Failure and leads research efforts aimed at improving outcomes in critically ill cardiovascular populations.
Deepak Acharya, MD, MSPH, MBA
Professor, Medicine
Division of Cardiology